1. Home
  2. NRXP vs LUXH Comparison

NRXP vs LUXH Comparison

Compare NRXP & LUXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • LUXH
  • Stock Information
  • Founded
  • NRXP 2015
  • LUXH 2017
  • Country
  • NRXP United States
  • LUXH United States
  • Employees
  • NRXP N/A
  • LUXH N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • LUXH Real Estate
  • Sector
  • NRXP Health Care
  • LUXH Finance
  • Exchange
  • NRXP Nasdaq
  • LUXH Nasdaq
  • Market Cap
  • NRXP 14.8M
  • LUXH 12.7M
  • IPO Year
  • NRXP N/A
  • LUXH N/A
  • Fundamental
  • Price
  • NRXP $1.16
  • LUXH $0.04
  • Analyst Decision
  • NRXP Strong Buy
  • LUXH Hold
  • Analyst Count
  • NRXP 3
  • LUXH 2
  • Target Price
  • NRXP $31.33
  • LUXH N/A
  • AVG Volume (30 Days)
  • NRXP 153.3K
  • LUXH 33.9M
  • Earning Date
  • NRXP 11-18-2024
  • LUXH 11-26-2024
  • Dividend Yield
  • NRXP N/A
  • LUXH N/A
  • EPS Growth
  • NRXP N/A
  • LUXH N/A
  • EPS
  • NRXP N/A
  • LUXH N/A
  • Revenue
  • NRXP N/A
  • LUXH $90,865,323.00
  • Revenue This Year
  • NRXP N/A
  • LUXH N/A
  • Revenue Next Year
  • NRXP N/A
  • LUXH $15.51
  • P/E Ratio
  • NRXP N/A
  • LUXH N/A
  • Revenue Growth
  • NRXP N/A
  • LUXH 14.73
  • 52 Week Low
  • NRXP $1.10
  • LUXH $0.03
  • 52 Week High
  • NRXP $7.33
  • LUXH $6.88
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 33.72
  • LUXH 39.09
  • Support Level
  • NRXP $1.23
  • LUXH $0.04
  • Resistance Level
  • NRXP $1.30
  • LUXH $0.06
  • Average True Range (ATR)
  • NRXP 0.10
  • LUXH 0.01
  • MACD
  • NRXP 0.00
  • LUXH 0.00
  • Stochastic Oscillator
  • NRXP 12.12
  • LUXH 21.67

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About LUXH LuxUrban Hotels Inc.

LuxUrban Hotels Inc utilizes a long term lease, asset-light business model to acquire and manage a growing portfolio of short-term rental properties in metropolitan cities. It identifies, acquires, manages, and markets hotel rooms to business and vacation travelers under the consumer brand, LuxUrban. It manages a portfolio of hotel rooms in New York, Washington D.C., Miami Beach, New Orleans and Los Angeles.

Share on Social Networks: